Inventor · disambiguated record
Shengfeng Li
Also filed as: LI SHENGFENG
20 granted patents·31 pending applications·420 citations·filing 1996–2023
93Inventor score
Files withBIO THERA SOLUTIONS LTD26BIO THERA SOLUTIONS LTD CO9COR THERAPEUTICS INC3ABMAXIS INC2LI SHENGFENG2
Top patents by PatentIndex Score
51 records- 0197US6833441B2Compositions and methods for generating chimeric heteromultimersABMAXIS INC·Filed 2001·Granted Dec 21, 2004·293 cites·38 claims
- 0295US7429652B2Compositions and methods for generating chimeric heteromultimersABMAXIS INC·Filed 2004·Granted Sep 30, 2008·78 cites·31 claims
- 0384US7179595B2Compositions and methods for generating antigen-binding unitsLI SHENGFENG·Filed 2002·Granted Feb 20, 2007·16 cites·15 claims
- 0481US9567403B2Bispecific antibodies which bind EGFR and VEGFBIO-THERA SOLUTIONS LTD CO·Filed 2014·Granted Feb 14, 2017·5 cites·2 claims
- 0580US11192954B2Compounds and methods for the treatment of TROP2 positive diseasesBIO THERA SOLUTIONS LTD·Filed 2018·Granted Dec 7, 2021·3 cites·18 claims
- 0679US6322990B1Methods of identifying agents that block the interaction of a BAP protein with a signaling partnerFiled 2000·Granted Nov 27, 2001·4 cites·4 claims
- 0778US12146653B2Lighting unit having an LED array and lens plate with groovesSIGNIFY HOLDING BV·Filed 2021·Granted Nov 19, 2024·1 cites·13 claims
- 0873US9314536B2Compounds and methods for the treatment of EGFR positive diseasesBIO THERA SOLUTIONS LTD CO·Filed 2013·Granted Apr 19, 2016·2 cites·2 claims
- 0973US7498410B2Bifunctional variants of recombinant tissue-type plasminogen activator with platelet aggregation inhibitory activityHUMAB SOLUTIONS INC·Filed 2006·Granted Mar 3, 2009·3 cites·11 claims
- 1072US9345786B2Maytansinoid derivativesBIO THERA SOLUTIONS LTD CO·Filed 2013·Granted May 24, 2016·2 cites·15 claims
- 1165US2023190649A1Liquid formulation of humanized antibody for treating il-6-mediated diseasesBIO THERA SOLUTIONS LTD·Filed 2022·Application pending·0 cites
- 1262US2025388667A1Anti-nectin-4 antibody and use thereofBIO THERA SOLUTIONS LTD·Filed 2023·Application pending·0 cites
- 1360US12477633B2Power conversion circuit for quick response and switching power supplyJOULWATT TECH CO LTD·Filed 2023·Granted Nov 18, 2025·0 cites·19 claims
- 1460US2025249114A1Method for treating her2-positive solid tumorBIO THERA SOLUTIONS LTD·Filed 2023·Application pending·0 cites
- 1559US2025333498A1Anti-cldn18.2 antibody, and antibody-drug conjugate and use thereofBIO THERA SOLUTIONS LTD·Filed 2023·Application pending·0 cites
- 1658US12371491B2Anti-TIGIT immunosuppressant and application thereofBIO THERA SOLUTIONS LTD·Filed 2020·Granted Jul 29, 2025·0 cites·16 claims
- 1758US2025262316A1Antibody-drug conjugate and application thereofBIO THERA SOLUTIONS LTD·Filed 2022·Application pending·0 cites
- 1858US2015151003A1Maytansinoid derivativesBIO THERA SOLUTIONS LTD CO·Filed 2014·Application pending·0 cites
- 1958US2025381283A1Method for treating solid tumorBIO THERA SOLUTIONS LTD·Filed 2023·Application pending·0 cites
- 2058US2025051450A1Use of anti-pd-l1/cd47 bispecific antibody in treatment of diseasesBIO THERA SOLUTIONS LTD·Filed 2022·Application pending·0 cites
- 2157US2002164698A1Identification of Bap-1, a protein that binds to integrin and is involved in integrin-mediated signal transductionCOR THERAPEUTICS INC·Filed 2001·Application pending·0 cites
- 2256US2025059274A1ANTI-FRa ANTIBODY, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOFBIO THERA SOLUTIONS LTD·Filed 2022·Application pending·0 cites
- 2356US2024269315A1Drug conjugate and use thereofBIO THERA SOLUTIONS LTD·Filed 2022·Application pending·0 cites
- 2454US2024400690A1Anti-b7-h3 antibody and application thereofBIO THERA SOLUTIONS LTD·Filed 2022·Application pending·0 cites
- 2553US10977230B2Data information processing method and data storage systemALIBABA GROUP HOLDING LTD·Filed 2018·Granted Apr 13, 2021·0 cites·15 claims
- 2652USD1067353SBaseballJINJIANG AIDSOON SPORTS GOODS CO LTD·Filed 2023·Granted Mar 18, 2025·1 cites·1 claims
- 2752US2023287126A1Anti-pd-l1 antibody and use thereofBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 2852US2022071901A1A liquid formulation of humanized antibody for treating il-6-mediated diseasesBIO THERA SOLUTIONS LTD·Filed 2018·Application pending·0 cites
- 2951US12466887B2Antibody binding to PD-1BIO THERA SOLUTIONS LTD·Filed 2020·Granted Nov 11, 2025·0 cites·12 claims
- 3051US6194557B1Nucleic acid molecules encoding Bap-1 proteinsCOR THERAPEUTICS INC·Filed 1996·Granted Feb 27, 2001·9 cites·16 claims
- 3151US2023416386A1Use of anti-ox40 antibody in treatment of tumor or cancerBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 3251US2024067728A1Bispecific antibody and use thereofBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 3351US2014178413A1Compounds and methods for the treatment of erb b2/neu positive diseasesBIO THERA SOLUTIONS LTD CO·Filed 2013·Application pending·0 cites
- 3451US2024228592A1Antibody and fusion protein for treating coronaviruses and use thereofBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 3551US2024092892A1Anti-cldn18.2 antibody, and preparation method therefor and use thereofBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 3651US2023303711A1Anti-cd47 antibody and use thereofBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 3750US11198820B2Conversion process for an organic materialBEIJING SANJU ENVIRONMENTAL PROT & NEW MATERIALS CO LTD·Filed 2019·Granted Dec 14, 2021·0 cites·56 claims
- 3850US2023203164A1Anti-ctla-4 monoclonal antibody, preparation method therefor, and application thereofBIO THERA SOLUTIONS LTD·Filed 2020·Application pending·0 cites
- 3950US2007243541A1Compositions and methods for generating antigen-binding unitsLI SHENGFENG·Filed 2006·Application pending·0 cites
- 4049US2017258935A1Compounds and methods for the treatment of erb b2/neu positive diseasesBIO-THERA SOLUTIONS LTD CO·Filed 2017·Application pending·0 cites
- 4149US2016200737A1Maytansinoid DerivativesBIO THERA SOLUTIONS LTD CO·Filed 2016·Application pending·0 cites
- 4248US11626804B2Power converter, method for driving switching transistors and a power supply system thereofHUAYUAN SEMICONDUCTOR SHENZHEN LTD COMPANY·Filed 2021·Granted Apr 11, 2023·0 cites·20 claims
- 4348US9737616B2Compounds and methods for the treatment of ERB B2/NEU positive diseasesBIO-THERA SOLUTIONS LTD CO·Filed 2015·Granted Aug 22, 2017·0 cites·2 claims
- 4448US2023173068A1ANTI-TNF-a ANTIBODY FORMULATION, PREPARATION METHOD THEREFOR AND USE THEREOFBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 4548US2003059888A1Compositions and methods for generating antigen-binding unitsFiled 2002·Application pending·0 cites
- 4648US2023139700A1Development and application of immune cell activatorBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 4747US2024002511A1Use of anti-pd-1 antibody in combination therapyBIO THERA SOLUTIONS LTD·Filed 2021·Application pending·0 cites
- 4846US2023338526A1Anti-cd20 antibody formulation and use of anti-cd20 antibody for treatment of cd20 positive diseasesBIO THERA SOLUTIONS LTD·Filed 2020·Application pending·0 cites
- 4942US2014178411A1Compounds and methods for the treatment of cd20 positive diseasesBIO THERA SOLUTIONS LTD CO·Filed 2013·Application pending·0 cites
- 5040US6060588ABap-1 proteinsCOR THERAPEUTICS INC·Filed 1997·Granted May 9, 2000·3 cites·6 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Shengfeng Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →